BioNTech SE - ADR Forecast, price target & analysts
Why the stock moved Beta
BioNTech SE - ADR Target price 2026 - Analyst rating & recommendation
BioNTech SE - ADR Classifications & Recommendation
BioNTech SE - ADR Price Target
| Target Price | $131.07 |
| Price | $96.96 |
| Potential |
35.18%
register free of charge
|
| Number of Estimates | 24 |
|
24 Analysts have issued a price target BioNTech SE - ADR 2027 .
The average BioNTech SE - ADR target price is $131.07.
This is
35.18%
register free of charge
$190.05
96.01%
register free of charge
$85.85
11.46%
register free of charge
|
|
| A rating was issued by 27 analysts: 21 Analysts recommend BioNTech SE - ADR to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioNTech SE - ADR stock has an average upside potential 2027 of
35.18%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.22 | 2.06 |
| 4.32% | 35.82% | |
| EBITDA Margin | 5.82% | -77.59% |
| 178.75% | 1,432.57% | |
| Net Margin | -39.59% | -78.42% |
| 63.70% | 98.10% |
24 Analysts have issued a sales forecast BioNTech SE - ADR 2026 . The average BioNTech SE - ADR sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an BioNTech SE - ADR EBITDA forecast 2026. The average BioNTech SE - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
23 BioNTech SE - ADR Analysts have issued a net profit forecast 2026. The average BioNTech SE - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -5.27 | -6.44 |
| 70.00% | 22.20% | |
| P/E | negative | |
| EV/Sales | 3.35 |
23 Analysts have issued a BioNTech SE - ADR forecast for earnings per share. The average BioNTech SE - ADR EPS is
This results in the following potential growth metrics and future valuations:
BioNTech SE - ADR...
Current BioNTech SE - ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Oct 07 2026 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Sep 08 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 31 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 08 2026 |
| UBS |
Locked
➜
Locked
|
Locked | May 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Oct 07 2026 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Sep 08 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 31 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 08 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
May 27 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
